BeiGene Canada Named a Great Place to Work®
MISSISSAUGA, ON, Jan. 9, 2023 /CNW/ – BeiGene Canada, a subsidiary of global pharmaceutical company BeiGene has been recognized as a Great Place to Work® following a thorough, independent analysis conducted by the Great Place to Work® Institute Canada. BeiGene joins leading Canadian organizations whose employees have created and excelled at fostering exemplary workplaces.
“We are extremely proud to have been certified as a Great Place to Work®,” said Peter Brenders, General Manager, BeiGene Canada. “Our strong culture is designed to help our employees be their best and continue to grow personally and professionally. This is incredibly important as we establish BeiGene in Canada with the goal to bringing patients and clinicians innovative, affordable, and accessible treatments. Our people are truly our most critical asset, and creating a supportive workplace is vital to their success, to the company and ultimately to Canadians.”
As part of a global pharmaceutical company deeply invested in oncology research and drug development, BeiGene Canada prides itself on a culture of excellence, driven by employee recognition, accommodation, opportunities, and incentives to grow personally and professionally, and work-life balance for all employees.
BeiGene Canada counts itself among an impressive roster of Canadian organizations to receive the highly recognized and credible Great Places to Work® certification. BeiGene Canada earned the certification following an evaluation of its culture and processes, using the Great Place to Work® Trust Index Score, with employee feedback factoring significantly in the overall assessment.
BeiGene Canada, a subsidiary of global pharmaceutical company BeiGene has been recognized as a Great Place to Work®. (CNW Group/BeiGene Canada)